|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5000 CAD | -1.96% |
|
-1.96% | +9.89% |
| 07-14 | PharmaCorp to Seek Acquisition Opportunities | CI |
| 07-14 | PharmaCorp Rx Closes C$11.5 Million Bought-Deal Offering of Share Units | MT |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 15.24M | -7.09% | - | - | - | -6.35x | |
| 10.5B | 7.32% | 5.37% | 9.32% | 7.03% | -7.43x | |
| 4.97B | 5.65% | 5.36% | 11.33% | 8.75% | -5.22x | |
| 7.03B | 4.99% | 7.6% | 10.5% | 12.24% | -1.07x | |
| 3.49B | 6.87% | 10.04% | 14.98% | 6.06% | -1.29x | |
| 2.72B | 8.14% | 9.08% | 30.3% | 12.4% | 0.71x | |
| 3.93B | 4.49% | 7.41% | 17.16% | 4.67% | -0.84x | |
| 2.71B | 6.77% | 9.78% | 49.2% | 14.9% | -0.5x | |
| 7.34B | 3.55% | 6.24% | 17.17% | - | -0.31x | |
| 1.45B | 3.4% | 5.02% | - | - | - | |
| 3.45B | -1.28% | -0.41% | -7.99% | -3.4% | 5.65x | |
| 2.69B | 2.29% | 4.33% | 17.95% | 4.87% | 1.97x | |
| 2.48B | 1.52% | 2.44% | 3.57% | 3.39% | -1.3x | |
| 1.8B | 4.78% | 6.95% | 23.35% | 6.29% | 2.51x | |
| 735M | 3.19% | 4.71% | 11.82% | - | -1.01x | |
| 784M | 3.17% | 4.21% | 31.35% | - | 0.65x | |
| 1.38B | 3.52% | 4.81% | 14.2% | 8.21% | 1.77x | |
| Average | 3.38B | 3.6% | 5.81% | 16.95% | 7.12% | -0.75x | |
| Weighted average by Cap. | 5.89B | 5.57% | 6.32% | 14.99% | 8.11% | -2.92x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
